Ameliorative Potentials of Cocoyam (Colocasia esculenta L.) and Unripe Plantain (Musa paradisiaca L.) on the Relative Tissue Weights of Streptozotocin-Induced Diabetic Rats
Aim. To investigate the ameliorating potentials of cocoyam (Colocasia esculenta L.) and unripe plantain (Musa paradisiaca L.) incorporated feeds on the renal and liver growths of diabetic rats, induced with 55 and 65?mg/kg body weight of Streptozotocin. Method. The blood glucose level of the rats was measured with a glucometer, the protein and glucose and specific gravity (SPGR) in the urine samples of the rats were measured using urine assay strips and urinometer respectively. The chemical composition and antioxidant screening of the test feeds were carried out using standard techniques. Results. Administration of the test feeds for 21 days to the diabetic rats of groups 4 and 5, resulted in 58.75% and 38.13% decreases in hyperglycemia and amelioration of their elevated urinary protein, glucose, SPGR, and relative kidney weights. The diabetic rats administered cocoyam incorporated feeds, had 2.71% and 19.52% increases in weight and growth rates, the diabetic rats administered unripe plantain incorporated feeds had 5.12% and 29.52% decreases in weight and growth rates while the diabetic control rats had 28.69%, 29.46%, 248.9% and 250.14% decreases in weights and growth rates. The cocoyam incorporated feeds contained higher antioxidants, minerals and phytochemicals except alkaloids than unripe plantain feed. Conclusion. Cocoyam and unripe plantain could be useful in the management of diabetic nephropathy. 1. Introduction Diabetes is one of the most challenging diseases of the 21st century that affects essential biochemical pathways of the body (carbohydrate, protein, and lipid metabolism) and whose prevalence is rising globally, including the rural Nigerian populations [1, 2]. Due to the inability of the modern therapy to control all the pathophysiological aspects of the disorder as well as the enormous cost it poses on the economy of the developing nations of the world, alternative strategies are urgently needed [3]. The use of medicinal plants in the traditional management of diabetes mellitus could play an important role in the lives of rural people, particularly in remote parts of developing countries which are poorly served with health facilities. During diabetes, the liver has been reported to decrease in weight due to enhanced catabolic processes such as glycogenolysis, lipolysis, and proteolysis, which is the outcome of lack of insulin in the liver cells while the kidney has been reported to increase in weight due to glucose overutilization and subsequent enhancement in glycogen synthesis [4], lipogenesis, and protein synthesis. These changes
References
[1]
F. A. Ime, I. J. Atangwho, I. Regina, I. Ejemot-Nwadiaro, H. I. Edisua, and U. Essien, “Hypoglycaemic effect and proximate composition of some selected Nigerian traditional diets used in management of diabetes mellitus,” European Journal of Food Research and Review, vol. 1, no. 2, pp. 94–101, 2011.
[2]
G. M. Karau, E. N. M. Njagi, A. K. Machocho, and L. N. Wangai, “Phytonutrient, mineral composition and in vitro antioxidant activity of leaf and stem bark powders of Pappea capensis (L.),” Pakistan Journal of Nutrition, vol. 11, no. 2, pp. 123–132, 2012.
[3]
World Health Organization, “Who launches the first global strategy on traditional medicine,” Press Release WHO 38, World Health Organization, Geneva, Switzerland, 2002.
[4]
C. Meyer, M. Stumvoll, V. Nadkarni, J. Dostou, A. Mitrakou, and J. Gerich, “Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus,” Journal of Clinical Investigation, vol. 102, no. 3, pp. 619–624, 1998.
[5]
G. L. Bakris and E. Ritz, “The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented,” Kidney International, vol. 75, no. 5, pp. 449–452, 2009.
[6]
NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases), Kidney Diseases in Diabetes, NIDDK, Bethesda, Md, USA, 2007.
[7]
C. O. Eleazu and P. N. Okafor, “Antioxidant effect of unripe plantain (Musa paradisiacae) on oxidative stress in alloxan induced diabetic rabbits,” International Journal of Medicine & Biomedical Research, vol. 1, no. 3, pp. 232–241, 2012.
[8]
I. C. Onwueme and W. B. Charles, “Cultivation of cocoyam,” in Tropical Root and Tuber Crops. Production, Perspectives and Future Prospects, vol. 126 of FAO Plant Production and Protection Paper, pp. 139–161, FAO, Rome, Italy, 1994.
[9]
L. L. Niba, “Processing effects on susceptibility of starch to digestion in some dietary starch sources,” International Journal of Food Sciences and Nutrition, vol. 54, no. 1, pp. 97–109, 2003.
[10]
Association of Official Analytical Chemists, Official Methods of Analysis, W. Horwitz, Ed., 13th edition, 1990.
[11]
J. B. Harbone, Comparative Biochemistry of the Flavonoids, Academic Press, New York, NY, USA, 1973.
[12]
G. I. Onwuka, Food Analysis and Instrumentation. Theory and Practice, Napthali Prints, 2005.
[13]
L. L. Mensor, S. M. Fabio, G. L. Gildor et al., “Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical methods,” Phytotherapy Research, vol. 15, pp. 127–130, 2001.
[14]
National Research Council (NRC), “Guide for the care and use of laboratory animals,” Publication 8523, National Institute of Health, Bethesda, Md, USA, 1985.
[15]
M. Habibuddin, H. A. Daghriri, T. Humaira, M. S. Al-Qahtani, and A. A. H. Hefzi, “Antidiabetic effect of alcoholic extract of Caralluma sinaica L. on streptozotocin-induced diabetic rabbits,” Journal of Ethnopharmacology, vol. 117, no. 2, pp. 215–220, 2008.
[16]
M. Ugarte, M. Brown, K. A. Hollywood, G. J. Cooper, P. N. Bishop, and W. B. Dunn, “Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA),” Genome Medicine, vol. 4, no. 4, article 35, 2012.
[17]
B. O. Ekpo, Practical Biochemistry for Medical Students, Fansmen Communications, 2006.
[18]
A. C. Deb, Concepts of Biochemistry, 2nd edition, 2006.
[19]
N. W. Tietz, Clinical Guide to Laboratory Tests, WB Saunders, Philadelphia, Pa, USA, 1975.
[20]
C. M. Clark Jr. and D. A. Lee, “Prevention and treatment of the complications of diabetes mellitus,” The New England Journal of Medicine, vol. 332, no. 18, pp. 1210–1217, 1995.
[21]
Z. M. Al-Amin, M. Thomson, K. K. Al-Qattan, M. Peltonen-Shalaby, and M. Ali, “Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats,” British Journal of Nutrition, vol. 96, no. 4, pp. 660–666, 2006.
[22]
J. B. Henry and J. C. Todd, Clinical Diagnosis and Management by Laboratory Methods, WB Saunders, Philadelphia, Pa, USA, 16th edition, 1979.
[23]
V. Vasundev, Fundamentals of Biochemistry, Textbook of Biochemistry, 2nd edition, 2006.
[24]
C. Johnson-Delaney, Animal Companion Medicine Handbook for Veterinarians, Zoological Education Network, 1996.
[25]
K. S. Vivek, “Streptozotocin: an experimental tool In diabetes and Alzheimer’s disease,” International Journal of Pharmaceutical Research and Development, vol. 2, no. 1, pp. 1–7, 2010, http://www.ijprd.com.
[26]
S. Malatiali, I. Francis, and M. Barac-Nieto, “Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats,” Experimental Diabetes Research, vol. 2008, Article ID 305403, 2008.
[27]
S.-I. Lee, J.-S. Kim, S.-H. Oh, K.-Y. Park, H.-G. Lee, and S.-D. Kim, “Antihyperglycemic effect of Fomitopsis pinicola extracts in streptozotocin-induced diabetic rats,” Journal of Medicinal Food, vol. 11, no. 3, pp. 518–524, 2008.
[28]
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000.
[29]
C. L. Broadhurst, M. M. Polansky, and R. A. Anderson, “Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro,” Journal of Agricultural and Food Chemistry, vol. 48, no. 3, pp. 849–852, 2000.
[30]
C. Niederau, M. Berger, and W. Stremmel, “Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?” Diabetologia, vol. 26, no. 6, pp. 441–444, 1984.
[31]
A. D. Mooradian, M. Failla, B. Hoogwerf, M. Maryniuk, and J. Wylie-Rosett, “Selected vitamins and minerals in diabetes,” Diabetes Care, vol. 17, no. 5, pp. 464–479, 1994.
[32]
B. O'Connell, “Select vitamins and minerals in the management of diabetes,” Diabetes Spectrum, vol. 14, pp. 133–148, 2001.
[33]
M. K. Song, M. J. Rosenthal, B. D. Naliboff, L. Phanumas, and K. W. Kang, “Effect of bovine prostate of zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus,” Metabolism, vol. 47, no. 1, pp. 39–43, 1998.
[34]
J. M. Fernández-Real, A. López-Bermejo, and W. Ricart, “Cross-talk between iron metabolism and diabetes,” Diabetes, vol. 51, no. 8, pp. 2348–2354, 2002.
[35]
C. Monago and A. Uwakwe, “Proximate composition and in vitro anti-sickling property of Nigeria Cyperus esculentus (tiger nut sedge),” Trees for Life Journal, vol. 4, no. 2, pp. 1–6, 2009.